Search papers, labs, and topics across Lattice.
College of Pharmacy, University of Utah, Salt Lake City
1
0
0
3
QALY-based cost-effectiveness analyses may undervalue treatments that extend survival in Duchenne Muscular Dystrophy, as delaying mortality alone can negatively impact the treatment's perceived value.
